moonslav59

The best "time" was probably when his mom talked him out of taking the reported $200M deal. Maybe had they comeback with $220 I guess, somehow, it's still Bloom's fault.

Top Red Sox Playoff OPS by Season (2003-2021) 35+ ABs 1.279 Papi '04 1.260 Kike '21 1.230 Youk '07 1.206 Papi '13 1.204 Papi '07 1.160 Manny '07 1.158 T Walker '03 1.135 JD M '21 1.105 JBay '08 1.084 Pearce '18 1.061 Nixon '03 1.057 VTek '03 1.028 Devers '21 1.018 Lowell '07

Top wRC+ Leaders from 2021-2022 (1000+ PAs) 1. Judge 179 13. Betts 138 16. Devers 137 25. Bogey 132 38. J Turner 125 40. JD M 123 51. Renfroe 118 57. Beni 113 85. Dugo 105 2017-2022 (2500+ PAs) 1. Trout 179 2. Judge 166 3. Soto 153 9. Betts 140 11. JD M 139 15. J Turner 136 26. Bogey 127 31. Devers 123 58. Beni 109 60. Story 109 89. JBJ 79 (91 qualified)

Awesome GA-OSU game and TCU-Mich was a pretty good one, too.

Hope you can find a way to have a .... Happy New Year!

At least you finally showed your true feelings on the Sox "deserving" this. It doesn't surprise me you feel this way.

Your true colors shining through.

Happy New Year!

Steamers Early OPS Projections: .855 Devers + .801 Casas + .768 Dugo+ .736 Story = but way more PAs .735 Arroyo .727 Dalbec + .708 Kike + and way more PAs They don't have Yoshiad or Turner projections, yet FWAR 3.1 Sale > 1.8 Hill '22 1.9 Whit > 1.5 Whil '22 1.5 Bello > 1.3 Bello '22 1.4 Pivetta = 1.5 Piv '22 1.3 Paxton ?? Kluber ??? 1.0 Nate '22 0.8 Houck = 0.7 '22 0.7 Martin> 0.5 Brasier '22 0.5 Schreiber 0.3 Jansen= Strahm 0.3 '22 0.3 Crawford, Brasier & Taylor = 0.3 Craw/0.3 Davis/0.1 Valdez 0.2 Joely ??? 0.1 Barnes, Mata, Kelly, Walter, Seabold ??? .660 McGuire (321 PAs) & .738 Wong (209 PAs) = Vaz/Plaw fWAR '22>'23 projected 6.1 Bogey/0.2 Arroyo>>> 1.2 Arroyo 4.9 Devers >4.4 Devers 2.4 Story/-0.3 Downs 1.7 Vaz/1.3 McGuire/0.1 Wong/-0.4 Plaw 1.3 Ref 1.0/-0.2 Pham/-0.3 JBJ/-0.4 Duran ??? Yoshida 1.2 Verdugo 1.0 JD ??? Turner 0.5 Kike 0.2 Casas/-0.1 Dalbec/-0.1 Hosmer/-0.2 Cordero

ZIPs projects 82-80- just 3 GB the Yanks in 2023. I'm not thinking 3 games behind the Yanks, but how delusional are they?

Its not hard to improve on horrible. Answer each of these Qs: Is Casas/Turner better than Dalbec/Cordero? A healthy Story > the 2022 Story? Same with Kike? Devers better in 2023 is likely? Yoshida > Dugo/Pham/Duran in LF? Dugo/Ref > JBJ/Ref/Duran in RF? Turner = the 2022 JD? Catchers = 2022 catchers? Pen way better than 2022, even without Whitlock? 43 more starts from Whit & Bello = 43 starts from Nate & Wacha? 26 starts from Kluber = 26 from Hill? Now, I know all of this will not come true all at once, but one by one, I think the odds are, I'm right on almost all of these. We got way worse at SS, and maybe worse at C and SP2 and SP3. The rest looks even or better and our ML ready depth in the minors is light years better, on paper. Prepare to be wrong, again. Tell me, specifically, which slots I got wrong, and why.

He was talking about defense.

To me, better than last year, but better than last place leaves a lot of gray area. People focus on losing Bogey and JD and then Nate, Wacha and Hill. Bogey & JD's production, in terms of runs was down. Nate, Wacha and Hill started enough games for 2, so we essentially lost 2 not 3 SP'ers. I like Bello, Whit and Kluber replacing those 60+ starts. We also are losing some really bad pitching and hitting, which total meaningful PA and IP totals. I like Yoshida and Turner. I'm counting on better from Story, Kike and Devers. I might end up being disappointed with Casas, but he has a low bar to beat from 2022 at 1B. I like our catching tandem better than Vaz & Plawecki. Our pen lost so many games for us, last year. They should actually win some for us in '23. SS and a couple slots in the rotation are the big question marks, but the other slots all look like plusses or equals, to me. I'm sure you'll tell me where I'm wrong. Bring it on! With your record of predicting Sox outcomes, the more bad ones, the better.

He's already improved enough on D to not be a minus. Devers Forevers!

I see Berti's D metrics in RF don't look good. I like that he can play 2B, too, making Arroyo tradable. MRojas and Berti for Duran, Murphy, Dalbec and ____?

I'm fine with his offensive projection. I'm not happy with subpar D in RF.

I think the days of acquiring a Pedro or Schilling for a couple decent prospects are over. The Sale trade ended up not being so much of a return as thought at the time, due to Moncada and Kopech not doing as well as many expected. The HRam for Beckett plus salary dump Lowell worked for us. Our big FA signings have been a mixed bag with Price and Lackey as the 2 biggest ones. I know signing deGrom or Rodon might have worked like some of the recent ones you just listed, but there are quite a few failures we could lits, too. I didn't see this FA class of SP'ers as being "the one" to splurge on. I thought trading for one made more sense. I'm not happy with Kluber being the only SP'er added, but I like him more than Heaney, Lugo and a few others near the same price. It's going to come down to Whit & Bello with maybe Mata or Sale stepping up. The rest just need to stay healthy and not suck.

My trade was based more on who can play RF on defense better. I think I've made better suggestions than this one.

Well, my domers pulled it out. Big games, tonight: Mich v TCU and GA vs Ohio St. My only hope at winning my bowl pool is for USC and Penn St to win. Even then, I think I can just place second. (I went with So. Carolina over ND!)

There is just no way a comp pick for Devers is acceptable. Lock him up by opening day, or trade him. Everyone knows my preference.

Rafaela is defensively ready, now. He's plus-plus in CF and apparently plus at SS and 2B, too. If he can hit just .675, he's likely going to have a pretty long ML career.

The 13 man pitching staff choices for opening day will surely be influenced by injuries and options remaining. Here are the options remaining. If none are listed, it's zero. SP Sale Paxton Kluber Whitlock 3 Bello Pivetta Crawford 2 Winckowski 2 Seabold 1 Mata 1 Walter 3 Murphy 3 Jansen Martin Houck 2 Schreiber 3 Barnes Joely Brasier Mills 1 Taylor 2 Kelly 3 German 3 DHern 1 Ort 2

I'd rather have a real RF'er with 3 years of control over our 4th LF'er with 2 years of control. Age only matters, if the controllable years are the same or outside of prime. (I guess you could say Yaz's years are all outside prime, so point well taken.)

There were also serious doubts about Lester's ability to comeback from cancer. I'm glad we stuck with him, and he thanked Boston for sticking with him as he battled cancer. Maybe sticking with some of our yong pitchers now, will lead to some good stories, even if not on the level Lester reached with us. I don't get the need to bash our own players before they get a real chance to show their skillset. It reminds me of Swihart saying he loves the Sox but hated on 37 out of the 40 guys on the roster, plus the manager, coaches, GM and owner. Brasier is another story. Have at him!

No, I think most of the best players struggled early in their ML careers, at some point. Maybe year 2 for some, but most struggle, and my point made was not that Wink and Seabold are comparable to Pedey, but that deciding so early is often a mistake. BTW, Bogey had an even longer waiting period than Pedey. .241 with a .662 OPS after his first 644 PAs. He then went .651 in his first 125 PAs of 2015. That's about .660 after780 PAs. .754 Dalbec in his 898 career PAs. .676 Cordero in his 726 career PAs. .622 Duran in his career 335 PAs. Again, I'm not projecting greatness, especially on the level of Pedey or Bogey, but totally giving up on anyone can end up being a mistake. Take Dalbec, it would have been a mistake to give up on him in 2021, but then it looked like we gave him too long of a chance in '22. It's not an easy call. I think Wink, Crawford and Seabold all deserve another significant chance before we cut ties with them, but probably not on the opening day roster, unless they look sharp in ST'ing. I don't doubt the odds are against Wink and Seabold becoming even decent role players, but giving up so early, after tiny sample sizes is not winning strategy, either.